MetLife Investment Advisors »

Maplight Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Maplight Therapeutics (MPLT) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Maplight Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Maplight Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maplight Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $172k 9.8k 17.57

More positions owned by MetLife Investment Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Inc Class A Cap Stk Cl (GOOGL)
Broadcom (AVGO)
Meta Platforms Inc Class A Cl A (META)
Alphabet Inc Class C Cap Stk Cl (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Berkshire Hathaway Inc Class B Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Vanguard Short-term Bond Index Fun Short Trm (BSV)
Visa Inc Class A Com Cl A (V)
Spdr S&p Etf Trust Tr Unit (SPY)

View all positions for MetLife Investment Advisors

Top funds holding Maplight Therapeutics

Novo A/S
Fcpm Iii Services B.v.
T. Rowe Price Investment Management
Goldman Sachs Group
BlackRock
Nan Fung Group Holdings
5AM Venture Management
Sanofi
Vanguard Group
Pivotal bioVenture Partners Investment Advisor
Perceptive Advisors
Velan Capital Investment Management
Siren
Geode Capital Management
Vestal Point Capital

View all funds holding Maplight Therapeutics